Molecular mechanisms of angiotensin II-induced vascular injury.
about
Pathobiology of wound healing after glaucoma filtration surgeryCombining use of captopril and losartan attenuates the progress of Streptococcus pneumoniae-induced tympanosclerosis through the suppression of TGF-β1 expression.Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis.Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells.Mediators leading to fibrosis - how to measure and control them in tissue engineering.Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin IIDiabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cellsImatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertensionCofilin1 is involved in hypertension-induced renal damage via the regulation of NF-κB in renal tubular epithelial cells.Mesenteric artery remodeling and effects of imidapril and irbesartan on it in spontaneously hypertensive ratsImproving vagal activity ameliorates cardiac fibrosis induced by angiotensin II: in vivo and in vitroAngiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways.ACE inhibitors - angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease.Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertensionRegulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin IIAngiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severity.Is transforming growth factor-β signaling activated in human hypertrophied prostate treated by 5-alpha reductase inhibitor?Angiotensin II-induced hypertension regulates AT1 receptor subtypes and extracellular matrix turnover in mouse retinal pigment epitheliumHypoxia-induced collagen synthesis of human lung fibroblasts by activating the angiotensin system.Reactive oxygen species, cell growth, cell cycle progression and vascular remodeling in hypertension.Role of host genetics in fibrosis.Total flavonoids from Plumula Nelumbinis suppress angiotensin II-induced fractalkine production by inhibiting the ROS/NF-κB pathway in human umbilical vein endothelial cells.Renal interstitial fibrosis and Angiotensin inhibition.Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.The Far Side of Vascular Injury: Nonconventional Vasoconstrictors, DNA-targeting Agents, and Agents Toxic to Vascular Smooth Muscle.Protective Role of Ramipril and Candesartan against Myocardial Ischemic Reperfusion Injury: A Biochemical and Transmission Electron Microscopical Study.Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome.Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II.The relation between obesity, abdominal fat deposit and the angiotensin-converting enzyme gene I/D polymorphism and its association with coronary heart disease.Use of small angle neutron scattering to study the interaction of angiotensin II with model membranes.Effect of chronic inhibition of converting enzyme on proximal tubule acidification.Rutaecarpine inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells.Angiotensin II Type 1 receptor (AGTR1) gene polymorphisms are associated with vascular manifestations in patients with systemic sclerosis (SSc).Synergistic effect of atorvastatin and cyanidin-3-glucoside against angiotensin II-mediated vascular smooth muscle cell proliferation and migration through MAPK and PI3K/Akt pathways.
P2860
Q28073856-9008A3DA-DA0F-418B-9444-BD32BC481E1CQ30426743-CD996781-B1F3-4BB6-8C17-5D968BCEBB80Q30828361-519112D2-568F-472C-AEF8-E4107D58B314Q33612309-6B3ACACC-3B6F-480B-957C-00A50E906DBEQ34159587-AF6DDA3B-0555-413E-970F-8E60B8CFACBCQ34264496-4970F013-A929-466D-882E-908F50178F8EQ34350546-F828A5DF-4329-4DD6-A5D5-F8A924576DC1Q35086481-8FBE34F4-745B-4F0F-9AAD-A52A4725BBE6Q35652125-D7775D27-EC9E-4446-9F23-77A26B39FCA1Q36142616-5D18A2B6-6B57-47E6-B872-77B42FC96AE3Q36308127-8936D7D9-4C71-48D9-87E6-044533341351Q36310106-8221E01D-50DE-4117-88A5-CDD9891F9416Q36310340-90D32C23-5F2E-4FF9-84D5-48C1324DA2CBQ36711399-6BCAAF56-BDDA-44BE-A3AE-39032708B58AQ36726341-12E5DC7A-737F-48B7-88C2-6D86CE894722Q36936578-1BBAAD3E-2101-4A8F-A6C9-429BDF3F7828Q37016739-55C1D324-A4CD-4728-A564-C992AC1288EEQ37231069-DCDEEE84-45A0-4195-ABAE-CC2E9134B467Q37338238-05EC18AE-0579-4C70-B619-D99751050BB5Q37347557-9BB9D1D3-B1A3-47ED-8DCD-9CEDA623523FQ37420926-3374602B-D8B6-4EAD-8410-27BE7BE66F48Q37608554-B24692FE-C190-4165-9BB8-E99886F76665Q37644559-2D1D8686-2163-4842-874D-BA82DE8FFEC6Q37709969-B7628886-2325-48A2-9A30-8A18BABD2799Q38181476-FC964367-15A7-4B08-9961-DBD90CCF59E7Q38454084-666BBA5C-D80C-4BDD-9D91-49F9277725D2Q38583684-7439D780-4997-4ED5-B698-28573AE667F5Q39217232-E4DBF305-D50C-4C59-89B8-4C1B982CD67CQ41369308-2C2CE4A8-BA69-4CD2-B9D3-A2670B9162C3Q41811073-18B4D1FB-7C04-49F3-AF8D-320D36EA881AQ41864365-19E9F726-7A56-48B0-B7E3-2D98F1B4EFE0Q42054472-D262F6A7-70B9-487B-B9F2-BA7E3E7F6173Q43115839-9673D3D3-398A-4A7A-935A-7172F4EF5197Q43246055-6EF37CD8-975C-45F4-B142-79188316D14FQ45134470-8C589D8E-A5CC-4617-8CC0-0CDCFD938A85Q46056805-E1871B63-8DD1-4C9A-B6CC-281AD0159680Q46653881-F6B40E07-AAFE-415B-BB3D-9219AF1639C4Q50899977-E22CEBB6-5FEC-4EB3-9B17-34579ED2EA8FQ51476905-3612B411-956D-4952-AFCB-291EFC628DFBQ51511108-A2C47994-571D-492B-9658-5449672F0E8D
P2860
Molecular mechanisms of angiotensin II-induced vascular injury.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular mechanisms of angiotensin II-induced vascular injury.
@en
type
label
Molecular mechanisms of angiotensin II-induced vascular injury.
@en
prefLabel
Molecular mechanisms of angiotensin II-induced vascular injury.
@en
P2860
P50
P1476
Molecular mechanisms of angiotensin II-induced vascular injury
@en
P2093
Jesús Egido
Monica Ruperez
P2860
P2888
P356
10.1007/S11906-003-0014-0
P577
2003-02-01T00:00:00Z